Skip to main content
Clinical Trials/NCT05856110
NCT05856110
Recruiting
Not Applicable

Coronary Computed Tomography Angiography and Functional Analysis in Risk Stratification of Coronary Artery Disease: A Prospective, Multi-center Cohort Study

Ruijin Hospital9 sites in 1 country2,000 target enrollmentJuly 3, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Ruijin Hospital
Enrollment
2000
Locations
9
Primary Endpoint
Major Adverse Cardiovascular Events
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This study is a multicenter, prospective clinical cohort study. The study intends to continuously enroll patients with coronary heart disease. All subjects will undergo coronary CTA (followed by anatomic, functional and radiomics analysis), proteomics research as well as clinical follow-up of cardiovascular events. The purpose of this study is to establish a new, non-invasive cardiovascular disease risk stratification system.

Detailed Description

Coronary angiography has been the gold standard for the diagnosis of coronary heart disease and PCI decision-making. However, the value of CAG in risk stratification is limited due to its invasive nature and lack of ability to evaluate coronary physiology and plaque characteristics, which often leads to over-treatment or under-treatment. In recent years, with the development and improvement of imaging technology, the resolution and diagnostic accuracy of coronary artery CTA have been greatly improved, and the subsequent anatomy and function (non-invasive CT-FFR, etc.) have made the assessment of coronary artery lesion risk multi-dimensional. Comprehensive and accurate coronary artery CTA scan plays a positive role in establishing the appropriate standard for PCI and improving the prognosis of patients. However, the existing problems of coronary artery CTA are insufficient imaging studies, complex image analysis, inconsistent diagnostic criteria, and insufficient clinical evidence. This study is one of the series of clinical studies on the topic of "Risk Evaluation by COronary Computed Tomography and Artificial Intelligence Based fuNctIonal analyZing tEchniques (RECOGNIZE)". The purpose of the study is to evaluate the accuracy of early identification of cardiovascular high-risk groups based on the functional evaluation model based on coronary CTA images through a multi-center, prospective clinical cohort study, so as to establish an early, non-invasive and accurate risk classification of cardiovascular events in coronary heart disease.

Registry
clinicaltrials.gov
Start Date
July 3, 2023
End Date
December 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

RUIYAN ZHANG

Director of Cardiology, Director of cardiovascular catherization lab, Principle Investigator

Ruijin Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 18-80 years
  • Clinically significant angina pectoris, suspecting coronary artery disease

Exclusion Criteria

  • Unsuitable for coronary CTA (such as severe renal impairment, uncontrolled thyroid condition, allergic to iodine, etc.)
  • Without a visible plaque (defined as ≥ 30% stenosis) in major coronary arteries in coronary CTA
  • Prior history of myocardial infarction or heart failure
  • Prior history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)
  • Severe renal or liver failure
  • Familial hypercholesterolemia
  • Estimated survival ≤1 year
  • Malignant tumor
  • Poor coordinance, unable to follow-up

Outcomes

Primary Outcomes

Major Adverse Cardiovascular Events

Time Frame: 2 years

Including cardiovascular death, myocardial infarction, and stroke

Secondary Outcomes

  • Myocardial infarction(2 years)
  • Cardiovascular death(2 years)
  • Stroke(2 years)
  • Coronary Revascularization(2 years)

Study Sites (9)

Loading locations...

Similar Trials